Global /France /Healthcare /Drug Manufacturers - General /VIRP
chevron_leftBack

Virbac S.A.

VIRP
• EPA: VIRP • Delayed
305.40EUR 0.7%
346.09 USD
As of 24 April 2025, Virbac S.A. has a market cap of $2.89B USD, ranking #4280 globally and #85 in France. It ranks #377 in the Healthcare sector, and #34 in the Drug Manufacturers - General industry.
Global Rank
4280
Country Rank
85
Sector Rank
377
Industry Rank
34
Key Stats
Market Cap
$2.89BUSD
2.54B EUR
Enterprise Value
$3.06BUSD
2.7B EUR
Revenue (TTM)
$1.59BUSD
1.4B EUR
EBITDA (TTM)
$308.32MUSD
272.07M EUR
Net Income (TTM)
$165.33MUSD
145.29M EUR
EBITDA Margin
19%
Profit Margin
10%
PE Ratio
17.5
Company Profile
Country (HQ)
France
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Habib Ramdani open_in_new
Employees
5,620
Founded
1968
Website
corporate.virbac.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.7% -0.9% 0.1% -2.1% -15% -15%

Markets

Exchange Ticker Price
Euronext Paris
MIC: XPAR
PRIMARY
VIRP
Virbac SA
ISIN: FR0000031577
Shares Out.:
8.375M1 Shares Float: 4.008M2
TV:
EURONEXT: VIRP
SA:
EPA: VIRP
YF:
VIRP.PA
GF:
EPA: VIRP
BA:
VIRP
MS:
XPAR: VIRP
305.40 EUR
London Stock Exchange
MIC: XLON
0NM7
Virbac SA
ISIN: FR0000031577
TV:
LSE: 0NM7
SA:
LON: 0NM7
YF:
0NM7.L
GF:
LON: 0NM7
BA:
0NM7
MS:
XLON: 0NM7
298.15 EUR
OTC Markets
MIC: OTCM
VRBCF
Virbac SA
ISIN: FR0000031577
TV:
OTC: VRBCF
SA:
OTC: VRBCF
YF:
VRBCF
GF:
OTCMKTS: VRBCF
BA:
VRBCF
MS:
PINX: VRBCF
324.00 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Virbac S.A.

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Similar Companies

Industry: Drug Manufacturers - General (France)
Name
Market Cap diff.
Sanofi
SAN
$129.87B
114.13B EUR
4K%
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
Eli Lilly and Co.
LLY
$744.81B
26K%
Johnson & Johnson
JNJ
$374.44B
13K%
AbbVie Inc.
ABBV
$313.2B
11K%
Novo Nordisk A/S
NOVO-B
$276.68B
1.82T DKK
9K%
Roche Holding AG
RO
$246.36B
204.44B CHF
8K%